Aegon Ltd. (NYSE:AEG – Get Free Report) saw a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 3,350,000 shares, a growth of 6.0% from the August 31st total of 3,160,000 shares. Currently, 0.2% of the shares of the stock are short sold. Based on an average trading volume of 2,270,000 shares, the days-to-cover ratio is currently 1.5 days.
Aegon Stock Performance
NYSE:AEG opened at $6.22 on Wednesday. The company has a 50-day moving average of $6.15 and a 200-day moving average of $6.23. The firm has a market cap of $13.71 billion, a price-to-earnings ratio of 6.76 and a beta of 1.07. The company has a current ratio of 0.07, a quick ratio of 0.08 and a debt-to-equity ratio of 0.52. Aegon has a twelve month low of $4.63 and a twelve month high of $6.96.
Aegon Cuts Dividend
The business also recently declared a semi-annual dividend, which was paid on Thursday, September 26th. Shareholders of record on Thursday, September 5th were issued a $0.1723 dividend. The ex-dividend date was Thursday, September 5th. This represents a dividend yield of 4.9%. Aegon’s dividend payout ratio is currently 32.61%.
Institutional Investors Weigh In On Aegon
Aegon Company Profile
Aegon Ltd. provides insurance, pensions, retirement, and asset management services in the United States, the Netherlands, the United Kingdom, and internationally. The company offers life, accident, property and casualty, and health insurance; annuities, retirement plans, mutual funds, and stable value solutions; residential mortgage and digital baking services; and retail and institutional investment management solutions and retirement savings vehicles and strategies.
Featured Articles
- Five stocks we like better than Aegon
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What is a support level?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How to Use the MarketBeat Dividend Calculator
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Aegon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aegon and related companies with MarketBeat.com's FREE daily email newsletter.